Cheaper drugs and ingredients from China and India are becoming an increasing part of U.S. sales of generics and over-the-counter drugs without FDA oversight. The agency rarely conducts quality-control inspections in the two countries, even after an ingredient in a Chinese drug caused dozens of deaths in Haiti a decade ago and again recently in Panama.

Related Summaries